EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Are different angiotensin converting enzyme inhibitors identical for treatment of acute myocardial infarction? Results from the Hong-Kong post-myocardial infarction trial



Are different angiotensin converting enzyme inhibitors identical for treatment of acute myocardial infarction? Results from the Hong-Kong post-myocardial infarction trial



European Heart Journal 20(ABSTR SUPPL ): 287




(PDF emailed within 1 workday: $29.90)

Accession: 034437660

Download citation: RISBibTeXText



Related references

ASS, Beta Blocker and angiotensin-converting enzyme inhibitors as an initial therapy for acute myocardial infarction Results from the Berlin Myocardial Infarction Registry. European Heart Journal 23(Abstract Supplement): 726, August-September, 2002

Comparative Effectiveness of Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors Following Contemporary Treatments in Patients with Acute Myocardial Infarction: Results from the Korean Working Group in Myocardial Infarction (KorMI) Registry. American Journal of Cardiovascular Drugs 15(6): 439-449, 2016

Lack of adverse long-term prognostic effect of aspirin therapy in patients treated with angiotensin converting enzyme inhibitors after myocardial infarction Results from a nationwide French registry of acute myocardial infarction. Journal of the American College of Cardiology 37(2 Supplement A): 274A, February, 2001

Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: Data from the National Registry of Myocardial Infarction 2. Journal of the American College of Cardiology 32(2): 360-367, 1998

Effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction: a possible mechanism of prevention of cardiac events by angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk myocardial infarction. Internal Medicine 48(11): 877-882, 2010

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group. Journal of the American College of Cardiology 35(7): 1801-1807, 2000

Do we have to treat asymptomatic patients after myocardial infarction with angiotensin-converting enzyme inhibitors and betablockers? Results from the ABC-Trial. European Heart Journal 23(Abstract Supplement): 588, August-September, 2002

Beneficial effects of angiotensin-converting enzyme inhibitor and nitrate association on left ventricular remodeling in patients with large acute myocardial infarction: the Delapril Remodeling after Acute Myocardial Infarction (DRAMI) trial. American Heart Journal 146(1): 133-133, 2003

Treatment of acute myocardial infarction patients with angiotensin converting enzyme inhibitors. Cor et Vasa 35(2): K39-K41, 1993

Effects of canrenoate plus angiotensin-converting enzyme inhibitors versus angiotensin-converting enzyme inhibitors alone on systolic and diastolic function in patients with acute anterior myocardial infarction. American Heart Journal 150(5): 919-919, 2005

Comparing angiotensin-converting enzyme inhibitor trial results in patients with acute myocardial infarction. Archives of Internal Medicine 154(18): 2029-2036, 1994

Risk/benefit ratio of early treatment with angiotensin-converting enzyme inhibitors after acute myocardial infarction in patients with a history of hypertension Results of the GISSI-3 data base. European Heart Journal 18(ABSTR SUPPL ): 167, 1997

Angiotensin-converting enzyme inhibitors post-myocardial infarction. Cardiology Clinics 13(3): 379-390, 1995

Long-term treatment with angiotensin-converting enzyme inhibitors, beta-blockers or a combination of angiotensin-converting enzyme inhibitors and beta-blockers in low-risk patients after acute myocardial infarction: The ABC study. HeartDrug 1(1): 20-25, January-February, 2001

Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction. American Journal of Cardiology 105(9): 1229-1234, 2010